Why the study?
Does Coronary Artery Calcium assessment improve risk assessment for ASCVD in adults with a family history of premature coronary heart disease compared to CIMT?
Does Coronary Artery Calcium assessment improve risk assessment for ASCVD in adults with a family history of premature coronary heart disease compared to CIMT?
Answers are grounded in this paper and cite their sources.
CAC, but not CIMT, is a robust marker of ASCVD risk in adults with a family history of premature coronary heart disease, identifying a large subgroup with zero CAC who may derive less benefit from preventive therapies.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Patel et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: